国际麻醉学与复苏杂志   2023, Issue (3): 0-0
    
瑞马唑仑对脑血管介入手术患者术后谵妄的影响
张君宝, 张昊鹏, 白晓光, 张久祥, 李慧, 朱菲, 路志红, 王小慧1()
1.空军军医大学西京医院麻醉与围术期医学科
Effect of remimazolam on postoperative delirium in patients undergoing endovascular neurosurgery
 全文:
摘要:

目的 观察瑞马唑仑对脑血管介入手术患者术后谵妄(postoperative delirium, POD)的影响。 方法 选取2021年7月至2022年6月在空军军医大学西京医院行全麻下脑血管介入手术的患者,采用区组随机化方法分为丙泊酚组(P组)和瑞马唑仑组(R组)。P组患者静脉注射丙泊酚1.0~1.5 mg/kg行麻醉诱导,静脉泵注丙泊酚4~10 mg·kg−1·h−1术中维持麻醉;R组患者静脉注射瑞马唑仑0.1 mg/kg行麻醉诱导,静脉泵注瑞马唑仑0.3~0.7 mg·kg−1·h−1术中维持麻醉。记录两组患者一般情况、术前合并疾病情况、手术时长及术中血管活性药物使用情况。于术前20 min和术后5 min采集两组患者静脉血样本,双抗体夹心ABC‑ELISA法检测血清IL‑6、血清S100钙结合蛋白β(S100 calcium binding protein β, S100β)和TNF‑α水平。采用ICU意识模糊评估法(Confusion Assessment Method‑intensive care unit, CAM‑ICU)量表于拔管后30 min、术后1 d和术后3 d进行POD评估。 结果 共129例患者完成研究,其中P组64例,R组65例。两组患者一般情况、术前合并疾病情况、手术时长差异无统计学意义(P>0.05)。两组患者拔管后30 min、术后1 d和术后3 d POD发生率差异无统计学意义(P>0.05)。两组患者术前、术后的IL‑6、TNF‑α和S100β水平差异均无统计学意义(P>0.05);与术前比较,两组患者术后IL‑6、TNF‑α和S100β水平差异无统计学意义(P>0.05)。R组术中升压药使用率低于P组(P<0.05),两组患者术中降压药和阿托品使用率差异均无统计学意义(P>0.05)。 结论 与丙泊酚相比,瑞马唑仑全麻不会增加脑血管介入手术患者POD发生率,也不引起血清IL‑6、TNF‑α及S100β水平的显著变化。

关键词: 瑞马唑仑; 术后谵妄; 炎症因子; 脑血管疾病; 介入手术
Abstract:

Objective To observe the effect of remimazolam on postoperative delirium (POD) in patients undergoing endovascular neurosurgery. Methods Patients who were scheduled for endovascular neurosurgery under general anesthesia in Xijing Hospital, Air Force Medical University from July 2021 to June 2022 were selected. According to the block randomization method, they were divided into two groups: group propofol (group P) and group remimazolam (group R). Patients in group P were intravenously injected with 1.0‒1.5 mg/kg of propofol for anesthesia induction, followed by intravenous infusion of propofol at 4‒10 mg·kg−1·h−1 for maintenance. Meanwhile, patients in group R were intravenously injected with 0.1 mg/kg of remimazolam for anesthesia induction, followed by intravenous infusion of remimazolam at 0.3‒0.7 mg·kg−1·h−1 for maintenance. Then, both groups were compared for general information, preoperative comorbidities, the duration of operation, and intraoperative use of vasoactive agents. Venous blood samples were collected 20 min before surgery and 5 min after surgery. The levels of serum interleukin (IL)‑6, S100 calcium binding protein β (S100β) and tumor necrosis factor‑α (TNF‑α) were detected by double antibody sandwich ABC‑enzyme‑linked immunosorbent assay (ELISA) method. Furthermore, the Confusion Assessment Method‑intensive care unit (CAM‑ICU) was used to evaluate delirium 30 min after extubation, and at postoperative 1 d and 3 d. Results A total of 129 patients completed the study, including 64 patients in group P and 65 patients in group R. There was no statistical difference in general information, preoperative comorbidities and the duration of operation between the two groups (P>0.05). There was no statistical difference in the incidence of POD between two groups 30 min after extubation, and at postoperative 1 d and 3 d (P>0.05). There was no statistical difference in the levels of serum IL‑6, TNF‑α and S100β between two groups before and after surgery (P>0.05). Compared with those before surgery, there was no statistical difference in IL‑6,TNF‑α and S100β levels between the two groups after surgery (P>0.05). Group R presented a lower rate of vasopressor use than group P (P<0.05), and no statistical difference was found in the rate of antihypertensive agent and atropine use between the two groups (P>0.05). Conclusions Compared with propofol, remimazolam for general anesthesia does not increase the incidence of POD after endovascular neurosurgery, without significant changes in the levels of serum IL‑6, TNF‑α and S100β.

Key words: Remimazolam; Postoperative delirium; Inflammatory marker; Cerebrovascular disorder; Intervention therapy